ArticleBMC biotechnology2005
Effects of DNA mass on multiple displacement whole genome amplification and genotyping performance.
Article in BMC biotechnology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 73 citations in OpenAlex.
- Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays.BMC genomics · 2018Article
- Comparative study of whole genome amplification and next generation sequencing performance of single cancer cells.Oncotarget · 2017Article
- Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications.BMC cancer · 2017Article
- Improved DOP-PCR (iDOP-PCR): A robust and simple WGA method for efficient amplification of low copy number genomic DNA.PloS one · 2017Article
- Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform.International journal of molecular sciences · 2015Article
- Article
- A mechanistic basis for amplification differences between samples and between genome regions.BMC genomics · 2012Article
- Characterization of whole genome amplified (WGA) DNA for use in genotyping assay development.BMC genomics · 2012Article
- Microarray-based evaluation of whole-community genome DNA amplification methods.Applied and environmental microbiology · 2011Article
- Collection of human genomic DNA from neonates: a comparison between umbilical cord blood and buccal swabs.American journal of obstetrics and gynecology · 2011Article
- Genotyping performance assessment of whole genome amplified DNA with respect to multiplexing level of assay and its period of storage.PloS one · 2011Article
- Assessing the utility of whole-genome amplified serum DNA for array-based high throughput genotyping.BMC genetics · 2009Article
- Microbial communities in subpermafrost saline fracture water at the Lupin Au mine, Nunavut, Canada.Microbial ecology · 2009Article
- 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects.BMC medical genetics · 2009Article
- Whole genome amplification and real-time PCR in forensic casework.BMC genomics · 2009Article
- A population-based association study of glutamate decarboxylase 1 as a candidate gene for autism.Journal of neural transmission (Vienna, Austria : 1996) · 2009Article
- Multiple displacement amplification for malaria parasite DNA.The Journal of parasitology · 2009Article
- Whole-genome amplification enables accurate genotyping for microarray-based high-density single nucleotide polymorphism array.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2008Article
- A procedure for highly specific, sensitive, and unbiased whole-genome amplification.Proceedings of the National Academy of Sciences of the United States of America · 2008Article
- Performance of amplified DNA in an Illumina GoldenGate BeadArray assay.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundWhole genome amplification (WGA) promises to eliminate practical molecular genetic analysis limitations associated with genomic DNA (gDNA) quantity. We evaluated the performance of multiple displacement amplification (MDA) WGA using gDNA extracted from lymphoblastoid cell lines (N = 27) with a range of starting gDNA input of 1-200 ng into the WGA reaction. Yield and composition analysis of whole genome amplified DNA (wgaDNA) was performed using three DNA quantification methods (OD, PicoGreen and RT-PCR). Two panels of N = 15 STR (using the AmpFlSTR Identifiler panel) and N = 49 SNP (TaqMan) genotyping assays were performed on each gDNA and wgaDNA sample in duplicate. gDNA and wgaDNA masses of 1, 4 and 20 ng were used in the SNP assays to evaluate the effects of DNA mass on SNP genotyping assay performance. A total of N = 6,880 STR and N = 56,448 SNP genotype attempts provided adequate power to detect differences in STR and SNP genotyping performance between gDNA and wgaDNA, and among wgaDNA produced from a range of gDNA templates inputs.
resultsThe proportion of double-stranded wgaDNA and human-specific PCR amplifiable wgaDNA increased with increased gDNA input into the WGA reaction. Increased amounts of gDNA input into the WGA reaction improved wgaDNA genotyping performance. Genotype completion or genotype concordance rates of wgaDNA produced from all gDNA input levels were observed to be reduced compared to gDNA, although the reduction was not always statistically significant. Reduced wgaDNA genotyping performance was primarily due to the increased variance of allelic amplification, resulting in loss of heterozygosity or increased undetermined genotypes. MDA WGA produces wgaDNA from no template control samples; such samples exhibited substantial false-positive genotyping rates.
conclusionThe amount of gDNA input into the MDA WGA reaction is a critical determinant of genotyping performance of wgaDNA. At least 10 ng of lymphoblastoid gDNA input into MDA WGA is required to obtain wgaDNA TaqMan SNP assay genotyping performance equivalent to that of gDNA. Over 100 ng of lymphoblastoid gDNA input into MDA WGA is required to obtain optimal STR genotyping performance using the AmpFlSTR Identifiler panel from wgaDNA equivalent to that of gDNA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.